Although several reasons have been proposed for dissatisfaction and poor outcomes post TKA, it has been suggested that a certain proportion of such patients may be suffering from implantrelated metal hypersensitivity [2] [3] [4] . Cutaneous metal hypersensitivity, as demonstrated by skin patch testing, is common with an estimated prevalence of 10%-17% in the general population [5] [6] [7] [8] [9] . Often, this hypersensitivity is caused by metals such as nickel, palladium, cobalt, and chrome 2) . Currently, there is uncertainty as to the role of metal hypersensitivity-related symptoms in patients with deep seated implants 4, 10, 11) . Previous works have suggested that the use of standard implants in patients with metal hypersensitivity may be linked to aseptic loosening, deep localised inflammatory reactions, as well as ongoing pain [12] [13] [14] . Previous research has highlighted various clinical strategies that can be adopted by arthroplasty surgeons when faced with patients who complain of cutaneous metal hypersensitivity 2, 10) . It has been recommended that for patients reporting only mild cutaneous reactions, the use of conventional cobalt-chromium implants may be justified without additional investigation 2, 10) . However, for patients reporting substantial localised reactions or systemic reaction to the metals, patch testing should be performed, which can then guide the choice of metal implants to utilise [15] [16] [17] . 
Materials and Methods
TKA implants utilised in the United Kingdom and Sweden were identified from their respective 2013 National Joint Registries. Companies manufacturing/marketing these TKA implants were contacted via different modalities (emails, phone calls, and company representatives) and were questioned using a predesigned questionnaire with regard to the availability and characteristics (designs and materials) of their TKA implants.
results
Twenty-two companies were identified from the United Kingdom National Joint Registry. Of these, 13 replied to the questionnaire. Six implant companies failed to respond and we were unable to contact two others. Thirteen implant companies were identified from the Swedish joint registry, 10 of which also sold the same implants in the United Kingdom. The remaining 3 implant companies were contacted but failed to respond.
Hence, replies were obtained from 13 implant manufacturers, providing information in relation to 23 TKA implants. The characteristics of these implants are shown in Table 1 . Fifteen out of the 23 TKA systems had a "hypersensitivity-friendly" option for both tibial and femoral components, which was identical in terms of design and instrumentation to the conventional system. Twelve of the 15 knee systems are available off the shelf, and the other 3 systems need to be custom-made. One hypersensitivity knee system produced a partially coated implant. Nine implant systems offered completely coated "hypersensitivity-friendly" components. Five systems had implants made entirely from either titanium or oxidised zirconium materials.
discussion
Our results suggest that there is a substantial variation in the type of "hypersensitivity-friendly" implants available to knee surgeons. The majority of standard TKA systems are traditionally made with cobalt chromium alloy and occasionally titanium or zirconium. The cobalt chrome alloy does contain a mixture of metals including nickel that are linked to metal hypersensitivity. Hence, companies have developed metal "hypersensitivityfriendly" implants for use in such patients. Furthermore, in regards to the tibia, all polyethylene tibial components can also be deemed to be "hypersensitivity-friendly". An all polyethylene option has been shown in recent studies to have similar outcomes to modular tibial components 18) . These components have the effect of reducing cost and exposure to metal allergens when used in this subset of patients. All polyethylene components have some inherent disadvantages such as a lack of modularity (limiting intraoperative options), no option for liner removal in the setting of acute irrigation and debridement for infection, and no option for late liner exchange 19) . Our results suggest that designs of "hypersensitivity-friendly" implants fall into two categories: coated implants and the others that are made fully of materials alternative to cobalt chrome 20) . Most of the manufactures that responded had standard cobalt chrome implants coated with a superficial "hypersensitivityfriendly" metal layer (usually titanium nitride or zirconia nitride) which encapsulates the prosthesis. These implants can be made custom-made or be available off the shelf depending on the implant and manufacturer. The advantage of this method is that it allows the manufacturer to keep some of the tribological properties of cobalt chrome such as strength and durability 20) . Worryingly, this method of coating the implant could be affected by asperities and scratching that can occur to the prosthesis during implantation or during the lifetime of the implant from various modes of wear. If such asperities were to occur, then it could potentially expose the patient to the underlying metal and lead to a hypersensitivity reaction. Most manufacturers informed us the implants they produced were completely encapsulated with the "hypersensitivity-friendly" coating, including both the articulating and non-articulating surfaces (the part in contact with bone). One company coated only the articulating surface, due to concerns that coating the surface facing the bone could impair cementation.
Another method of manufacturing "hypersensitivity-friendly" implants is developing implants made entirely of non-cobalt chrome alloys. Such alternatives identified from this work were implants made entirely from titanium or zirconium alloys 21, 22) . These implants would reduce the risk of the patient being exposed to nickel, cobalt, and chrome due to asperities in the longterm 14, 15, 23) . A potential disadvantage of titanium implants is reduced strength compared to cobalt chrome alloys. Understanding which TKA system gives the options of con- ventional versus "hypersensitivity-friendly" implants may help surgeons decide which system to use routinely 24) . Surgeons may choose an implant system that gives the option of using a "hypersensitivity-friendly" prosthesis in a small subset of patients where there is a concern of severe metal hypersensitivity but allows for the same technique and instrumentation as the conventional prosthesis in most of the patients in their clinical practice. Unfortunately, joint registries do not report outcomes separately for conventional and "hypersensitivity-friendly" implants in terms of long-term survivorship although this would be of interest to clinicians.
There are several limitations of this work, including the fact that some implant companies failed to respond to our questions. Therefore, other implant variations may exist that are not included in this review. Furthermore, we investigated implants intended mainly for use in primary TKA, and we did not seek information with regards to components used in revision surgery or complex primary arthroplasty.
"Hypersensitivity-friendly" metal implants are designed to help surgeons manage patients with metal hypersensitivity. There is, however, no strong evidence for the type of implants best to use in patients that have mild local skin reactions to nickel, cobalt, or chromium [25] [26] [27] . Guidelines and expert consensus studies do recommend that conventional implants be used in most patients with mild local cutaneous metal hypersensitivity reactions reported by patients or determined by patch testing 10, 15, 28, 29) . Conversely, when there is a history of severe local cutaneous metal hypersensitivity reactions or generalised systemic reactions, it has been suggested that patients should be patch tested and appropriate "hypersensitivity-friendly" implants utilised 2, 10, 28, 30) . Future randomised trials comparing "hypersensitivity-friendly" implants with conventional implants with regard to clinical outcomes and survivorship would be of great value in determining the role of metal hypersensitivity in ongoing pain and aseptic loosening following TKA and in developing more robust guidelines for clinical practice. Inclusion in such studies of implants that have the same design and surgical technique for both the conventional and hypersensitivity option would be ideal. Hence, the information gathered in the current study could further help in the design of future trials.
conclusions
The results of this study can guide TKA surgeons in making informed choices about implants, and identifying implants that could be examined in future controlled studies comparing outcomes between "hypersensitivity-friendly" and conventional implants.
